Showing results (81-90 of 112) with videos related to
Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2018
BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear TranslocationDaniela Asslaber, Nathalie Wacht, Michael Leisch, et al.Blood|February 7, 2014
Tiam1/Rac1 signals contribute to the proliferation and chemoresistance, but not motility, of chronic lymphocytic leukemia cellsSebastian W Hofbauer, Peter W Krenn, Sylvia Ganghammer, et al.Physical Review Letters|September 8, 2018
Early Stages of Ultrafast Spin Dynamics in a 3d FerromagnetR Gort, K Bühlmann, S Däster, et al.Oncotarget|June 11, 2016
Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclonesThomas Melchardt, Clemens Hufnagl, David M Weinstock, et al.NPJ Schizophrenia|February 4, 2021
Increased random exploration in schizophrenia is associated with inflammationFlurin Cathomas, Federica Klaus, Karoline Guetter, et al.Oncogene|July 7, 2010
Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cellsP Desch, D Asslaber, D Kern, et al.The Annals of Pharmacotherapy|September 2, 2004
Lumiracoxib does not affect methotrexate pharmacokinetics in rheumatoid arthritis patientsStefan N Hartmann, Christiane M Rordorf, Slavica Milosavljev, et al.Journal of Cancer Research and Clinical Oncology|January 24, 2022
Ex vivo propagation in a novel 3D high-throughput co-culture system for multiple myelomaJohannes M Waldschmidt, Stefan J Fruttiger, Dagmar Wider, et al.Blood|June 11, 2021
CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cuesXiaobing Yu, Leonel Munoz-Sagredo, Karolin Streule, et al.The Review of Scientific Instruments|July 3, 2020
Compact setup for spin-, time-, and angle-resolved photoemission spectroscopyK Bühlmann, R Gort, A Fognini, et al.Pageof 12